Obesity Management & Bariatric Surgery – Review Flashcards

0.0(0)
studied byStudied by 0 people
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/50

flashcard set

Earn XP

Description and Tags

These flashcards cover key definitions, non-pharmacologic therapy, indications for pharmacotherapy, detailed drug facts, special population cautions, follow-up criteria, and bariatric surgery information from the Obesity Management & Bariatric Surgery lecture.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

51 Terms

1
New cards

What is the World Health Organization (WHO) definition of obesity?

A chronic, complex disease characterized by excessive fat deposits that can impair health and increase the risk of conditions such as diabetes, heart disease, cancers, and mobility issues.

2
New cards

Which measurement is most widely used to diagnose overweight or obesity?

Body Mass Index (BMI), calculated as weight in kilograms divided by height in meters squared (kg/m²).

3
New cards

Provide the BMI ranges for normal weight, overweight, and obesity (Class I–III).

Normal: 18.5–24.9 kg/m²; Overweight: 25.0–29.9 kg/m²; Obesity Class I: 30.0–34.9 kg/m²; Class II: 35.0–39.9 kg/m²; Class III (extreme): ≥40 kg/m².

4
New cards

At what waist circumference do men and non-pregnant women have higher risk for obesity-related conditions?

Men > 40 in (102 cm); Non-pregnant women > 35 in (89 cm).

5
New cards

What daily calorie reduction usually produces ~1 lb of weight loss per week?

A 500–750 kcal decrease per day.

6
New cards

List four evidence-based, reduced-calorie eating plans for weight loss mentioned in the lecture.

Mediterranean, Low-carbohydrate, Low-fat, DASH diet (others included Volumetric, High-protein, Vegetarian, Plate method).

7
New cards

How much aerobic exercise is recommended weekly for weight-loss therapy?

≥150 minutes of moderate-to-vigorous intensity aerobic activity spread over at least 3 days per week.

8
New cards

Name three key behavioral interventions that support weight loss.

Self-monitoring (food, exercise, weight), goal setting, and stress reduction (also stimulus control and social support).

9
New cards

Why are most OTC weight-loss supplements NOT recommended?

They often contain stimulants/excess caffeine, are generally ineffective, and can be harmful, especially in patients with heart disease.

10
New cards

What BMI criteria indicate starting prescription weight-loss medication?

BMI ≥ 30 kg/m² OR BMI ≥ 27 kg/m² with at least one weight-related comorbidity (e.g., diabetes, hypertension, dyslipidemia, sleep apnea).

11
New cards

State the dual mechanisms of action for phentermine/topiramate ER (Qsymia).

Phentermine: sympathomimetic releasing norepinephrine to increase satiety and decrease appetite; Topiramate: neurotransmitter-mediated appetite suppression (antiepileptic effect leading to increased satiety).

12
New cards

What is the boxed REMS concern for Qsymia?

Teratogenic risk; pregnancy must be avoided and negative pregnancy tests required.

13
New cards

Why should Qsymia be tapered when discontinued?

Abrupt discontinuation can precipitate seizures due to the topiramate component.

14
New cards

List two common CNS side effects of phentermine/topiramate.

Insomnia and anxiety or depression

15
New cards

Which weight-loss drug combines an opioid antagonist with an antidepressant?

Naltrexone/bupropion ER (Contrave).

16
New cards

Why must opioids be discontinued 7–14 days before starting Contrave?

Naltrexone blocks opioid receptors and can precipitate withdrawal in opioid-treated patients.

17
New cards

Name two major contraindications for Contrave.

Uncontrolled hypertension and seizure disorders (others: pregnancy, bulimia/anorexia, MAOI use within 14 days).

18
New cards

What food interaction is important for Contrave administration?

High-fat meals increase drug levels; Contrave should NOT be taken with fatty foods.

19
New cards

What is the shared boxed warning for liraglutide, semaglutide, and tirzepatide?

Risk of thyroid C-cell carcinoma (observed in animal studies; relevance to humans unknown).

20
New cards

At what target dose is liraglutide (Saxenda) administered for weight loss?

3 mg subcutaneously once daily.

21
New cards

How often is semaglutide (Wegovy) administered, and what is its target dose?

Once weekly; target dose 2.4 mg SC weekly.

22
New cards

What dual receptor activity does tirzepatide (Zepbound) possess?

It is both a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist and a GLP-1 receptor agonist.

23
New cards

List three common GI side effects shared by GLP-1/GIP agonists used for obesity.

Nausea, vomiting, and diarrhea (also constipation, pancreatitis risk, gallbladder disease).

24
New cards

Which weight-loss medication inhibits gastrointestinal and pancreatic lipases to reduce fat absorption by ~30 %?

Orlistat (Xenical Rx, Alli OTC).

25
New cards

Why should a multivitamin be taken at bedtime when using Orlistat?

Orlistat impairs absorption of fat-soluble vitamins (A, D, E, K); bedtime multivitamin helps replenish stores.

26
New cards

Give two counseling points to reduce GI side effects with Orlistat.

Use a low-fat diet with no more than 30 % of calories from fat and omit the dose if a meal is skipped or contains no fat.

27
New cards

Which class of agents (phentermine, diethylpropion, phendimetrazine, benzphetamine) is limited to short-term (≤12 weeks) use?

Sympathomimetic appetite suppressants/stimulants (C-IV or C-III controlled substances).

28
New cards

Why are stimulant appetite suppressants generally avoided in patients with cardiovascular disease?

They can cause tachycardia, elevated blood pressure, arrhythmias, and other adrenergic side effects.

29
New cards

What novel weight-loss drug targets the melanocortin-4 receptor (MC4R) pathway in specific genetic syndromes?

Setmelanotide (Imcivree).

30
New cards

Before prescribing setmelanotide, what must be confirmed?

Genetic testing demonstrating POMC, PCSK1, LEPR deficiency, or Bardet-Biedl syndrome–related MC4R pathway impairment.

31
New cards

Which weight-loss medications are specifically contraindicated during pregnancy?

All prescription weight-loss drugs.

32
New cards

Which weight-loss medication is contraindicated in uncontrolled hypertension and lowers seizure threshold?

Contrave (naltrexone/bupropion).

33
New cards

When should prescription weight-loss drugs be discontinued due to lack of efficacy?

If ≥5 % of baseline body weight is not lost after 12 weeks on the optimal dose.

34
New cards

What BMI thresholds make an adult eligible for bariatric (weight-loss) surgery under guidelines?

BMI ≥ 40 kg/m² or BMI ≥ 35 kg/m² with at least one obesity-related condition (e.g., diabetes, HTN, dyslipidemia, sleep apnea).

35
New cards

Name the ‘gold standard’ bariatric procedure discussed in the lecture.

Roux-en-Y gastric bypass surgery.

36
New cards

List two ways gastric bypass contributes to weight loss beyond stomach restriction.

Limits calorie/nutrient absorption and alters gut hormones to increase satiety and reverse metabolic syndrome.

37
New cards

Why are gallstones a potential complication after rapid weight loss from bariatric surgery?

Rapid fat mobilization increases cholesterol saturation in bile, leading to gallstone formation; ursodiol may be used prophylactically or therapeutically.

38
New cards

Which calcium salt is preferred after gastric bypass and why?

Calcium citrate because its absorption is not acid-dependent, compensating for bypassed duodenum and reduced gastric acidity.

39
New cards

Which vitamin/mineral deficiencies commonly contribute to post-bariatric anemia?

Vitamin B12 and iron deficiencies.

40
New cards

What lifelong supplementation is recommended to prevent fat-soluble vitamin deficiencies after malabsorptive bariatric surgery?

Vitamins A, D, E, and K.

41
New cards

Give two medication-related considerations immediately after gastric bypass surgery.

Some drugs may require dose reductions and may need to be crushed, given in liquid, or transdermal form for up to 2 months post-surgery.

42
New cards

What percentage of genetics contributes to BMI and body-fat distribution according to the lecture?

About 40 % for BMI and 50 % for body-fat distribution.

43
New cards

Name three medication classes commonly associated with unintended weight gain.

Second-generation antipsychotics (e.g., clozapine, olanzapine), insulin or sulfonylureas, corticosteroids (also TZDs, tricyclic antidepressants).

44
New cards

Why is BMI criticized as a measure of obesity?

It does not distinguish between fat and lean tissue (e.g., muscular individuals may have high BMI but low body fat).

45
New cards

What follow-up counseling should accompany every weight-loss medication appointment?

Reinforce diet, exercise, and behavioral interventions and monitor for drug side effects.

46
New cards

Identify two comorbidities the AACE/ACE guidelines flag as ‘disease risk’ associated with increasing BMI and waist circumference.

Type 2 diabetes mellitus and cardiovascular disease (others: hypertension).

47
New cards

Which GLP-1 agonist is FDA-approved for adolescents >12 years with BMI > 30 kg/m²?

Liraglutide (Saxenda).

48
New cards

How does waist-to-hip ratio differ from waist circumference in assessing obesity?

Waist-to-hip ratio predicts disease/death risk but is harder to measure accurately, whereas waist circumference is easier and used clinically.

49
New cards

What is the caloric value of 1 lb of body fat that guides weekly weight-loss calculations?

Approximately 3,500 kcal.

50
New cards

What weight-loss drug must be taken separately from levothyroxine by at least 4 hours?

Orlistat (Xenical Rx, Alli OTC).

51
New cards

Oily/fatty stools is a known side effect to which weight-loss drug?

Orlistat (Xenical Rx, Alli OTC).